Results 41 to 50 of about 80 (72)

Farmakoterapija suicidalnosti shizofrenih bolesnika

open access: yesMedicus, 2002
Suicidalnost je vrlo važna i česta pojava u shizofrenih bolesnika i javlja se kod do 50 % bolesnika tijekom života. Do 20 % shizofrenih bolesnika život završi suicidom. Suicidi shizofrenih bolesnika uz neka zajednička obilježja sa suicidima opće populacije imaju i specifična obilježja upravo za tu dijagnostičku skupinu.
Folnegović-Šmalc, Vera   +1 more
openaire   +3 more sources

Farmakoterapija neuralgije trigemini

open access: yes, 2023
The trigeminal nerve, also known as the fifth cranial nerve, has three main branches: the ophthalmic nerve, the maxillary nerve, and the mandibular nerve. Pain in trigeminal neuralgia commonly affects the innervation area of the maxillary and mandibular nerves.
openaire   +1 more source

Farmakoterapija fibrilacije atrija

open access: yesMedicus, 2010
Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. Prevalence and incidence increase significantly with age. Treatment strategy depends on numerous clinical parameters which also determine the type of AF (paroxysmal, persistent, permanent). The most important decision involves rhythm or rate control and defines the therapeutic
openaire   +1 more source

Farmakoterapija glioblastoma

open access: yes
Glioblastom (GBM) je najčešći i najagresivniji primarni tumor mozga u odraslih. Unatoč multimodalnom liječenju koje uključuje kiruršku resekciju, radioterapiju i kemoterapiju temozolomidom, bolest gotovo uvijek recidivira, a medijan preživljenja rijetko prelazi 13 mjeseci. Prema WHO klasifikaciji iz 2021.
openaire   +1 more source

Farmakoterapija zatajivanja srca

open access: yes, 2019
Objectives: This thesis has 2 objectives. The first one is to show how the view of chronic heart failure changed through history. The most important events in history are mentioned, ending with the final guidelines of European Cardiological Society from 2016.
openaire   +1 more source

Farmakoterapija glaukoma

Farmaceutski glasnik, 2011
Glaucoma is a slow progressive degeneration of the retinal ganglion cells (RGCs) and the optic nerve axons, leading to irreversible blindness if left undiagnosed and untreated. Although increased intraocular pressure is a major risk factor of glaucoma, other factors include increased glutamate levels, alterations in nitric oxide (NO) metabolism ...
Pelčić, Goran   +2 more
openaire   +3 more sources

Farmakoterapija hiperlipidemija

Pharmaca, 2010
Hiperlipidemija predstavlja jedan od glavnih čimbenika rizika za razvoj srčanožilnih bolesti koje su glavni uzrok mortaliteta u Hrvatskoj i odgovorne za oko 51% smrtnih slučajeva. Liječenje hiperlipidemije stoga ima veliko značenje, a temelji se na individualnom pristupu bolesniku.
Božikov, Velimir, Marušić, Srećko
openaire   +2 more sources

Farmakoterapija GERB-a

Medix (Zagreb), 2007
Abstract
Milić, Sandra   +2 more
openaire   +1 more source

Farmakoterapija astme

2022
Astma je kronična, heterogena bolest, karakterizirana kroničnom upalom dišnih puteva, koja predstavlja globalni problem. U 2019. godini od astme je bolovalo više od 250 milijuna ljudi u svijetu, od kojih je gotovo pola milijuna završilo smrtnim ishodom.
openaire  

Racionalna farmakoterapija

2000
Radi se o prikazima slucajeva bolesnika s megaloblastičnom anemijom i hemoragijskom ...
openaire   +1 more source

Home - About - Disclaimer - Privacy